These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32384455)
1. The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis. Gao G; Shi X; Long Y; Yao Z; Shen J; Shen L Medicine (Baltimore); 2020 May; 99(19):e20002. PubMed ID: 32384455 [TBL] [Abstract][Full Text] [Related]
2. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer. Ye F; Jin P; Cai X; Cai P; Cai H Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314 [TBL] [Abstract][Full Text] [Related]
3. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer. Salomonsson A; Micke P; Mattsson JSM; La Fleur L; Isaksson J; Jönsson M; Nodin B; Botling J; Uhlén M; Jirström K; Staaf J; Planck M; Brunnström H Cancer Med; 2020 Aug; 9(15):5609-5619. PubMed ID: 32491279 [TBL] [Abstract][Full Text] [Related]
6. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469 [TBL] [Abstract][Full Text] [Related]
7. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death. Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K Biomark Res; 2014; 2():11. PubMed ID: 24963396 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
9. The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis. Wang F; Zhang L; Xu H; Li R; Xu L; Qin Z; Zhong B J Cancer; 2019; 10(1):277-286. PubMed ID: 30662548 [No Abstract] [Full Text] [Related]
10. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer. Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis. Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045 [TBL] [Abstract][Full Text] [Related]
12. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study. Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K Biomark Res; 2017; 5():10. PubMed ID: 28293425 [TBL] [Abstract][Full Text] [Related]
13. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis. Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis. Zhou N; Gu Q Medicine (Baltimore); 2018 Mar; 97(12):e0195. PubMed ID: 29561443 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis. Dan B; Luo J; Li K; Chen S Oncol Res Treat; 2018; 41(1-2):47-50. PubMed ID: 29402861 [TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis. Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914 [TBL] [Abstract][Full Text] [Related]
17. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity. Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K Gene; 2019 Oct; 716():144025. PubMed ID: 31394177 [TBL] [Abstract][Full Text] [Related]
18. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis. Liang C; Dong H; Miao C; Zhu J; Wang J; Li P; Li J; Wang Z Oncotarget; 2018 Feb; 9(15):12323-12332. PubMed ID: 29552313 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis. Liu Y; Tang W; Xie L; Wang J; Deng Y; Peng Q; Zhai L; Li S; Qin X Tumour Biol; 2014 Apr; 35(4):3145-54. PubMed ID: 24258111 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis. Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]